recursionpharma.comBioTechFounded: 2013Funding to Date: $333.7MM
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.
For more details on financing and valuation for Recursion Pharmaceuticals, register or login.
Already registered? Click here to log in
To read this article and more news on Recursion Pharmaceuticals, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.